Haverford Trust CO Amgen Inc Transaction History

Haverford Trust CO

$9.7 Billion
Q4 2024

A detailed history of Haverford Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Haverford Trust CO holds 42,299 shares of AMGN stock, worth $13.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

42,299

Previous 42,870 1.33%

Holding current value

$13.1 Million

Previous $13.8 Million 20.19%

% of portfolio

0.11%

Previous 0.14%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$258.78 - $328.31 $147,763 - $187,465	-571 Reduced 1.33%	42,299 $11 Million
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $107,045 - $116,733	346 Added 0.81%	42,870 $13.8 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $1.01 Million - $1.23 Million	3,853 Added 9.96%	42,524 $13.3 Million
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $144,114 - $173,964	-536 Reduced 1.37%	38,671 $11 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $214,020 - $241,441	837 Added 2.18%	39,207 $11.3 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $12,025 - $14,930	-55 Reduced 0.14%	38,370 $10.3 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $109,706 - $129,725	-512 Reduced 1.31%	38,425 $8.53 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $588,182 - $716,896	-2,605 Reduced 6.27%	38,937 $9.41 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $146,579 - $186,246	-640 Reduced 1.52%	41,542 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $232,765 - $262,516	-1,037 Reduced 2.4%	42,182 $9.51 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $66,905 - $74,454	-290 Reduced 0.67%	43,219 $10.5 Million
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $628,427 - $695,205	-2,866 Reduced 6.18%	43,509 $10.5 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $658,889 - $754,038	-3,313 Reduced 6.67%	46,375 $10.4 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $509,448 - $596,880	-2,400 Reduced 4.61%	49,688 $10.6 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $7.72 Million - $8.56 Million	-33,035 Reduced 72.24%	12,696 $12.7 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $9.2 Million - $10.2 Million	39,392 Added 310.27%	52,088 $12.7 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $182,853 - $213,086	-824 Reduced 1.77%	45,731 $11.4 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $3.4 Million - $4.05 Million	-15,699 Reduced 25.22%	46,555 $10.7 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $63,824 - $70,978	272 Added 0.44%	62,254 $15.8 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $807,460 - $990,864	-4,082 Reduced 6.18%	61,982 $14.6 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $316,004 - $419,107	-1,734 Reduced 2.56%	66,064 $13.4 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $160,260 - $205,990	847 Added 1.27%	67,798 $16.3 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $5,397 - $6,467	-31 Reduced 0.05%	66,951 $13 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $55,010 - $64,485	-330 Reduced 0.49%	66,982 $12.3 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $81,934 - $92,357	-453 Reduced 0.67%	67,312 $12.8 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $70,824 - $82,675	397 Added 0.59%	67,765 $13.2 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $18,899 - $21,306	-102 Reduced 0.15%	67,368 $14 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $7,970 - $8,952	-48 Reduced 0.07%	67,470 $12.5 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $68,110 - $79,596	-402 Reduced 0.59%	67,518 $11.5 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $775,083 - $866,005	4,592 Added 7.25%	67,920 $11.8 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $97,362 - $111,162	582 Added 0.93%	63,328 $11.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	62,746	62,746 $10.8 Million

Others Institutions Holding AMGN

# of Institutions

3,173

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Account

Haverford Trust CO Amgen Inc Transaction History